In addition, the expression of BTG2, CD69, GPC3, and IL7R were considerably elevated in tumor stages III-IV as opposed to tumor stage I-II (p < 0.05, Supplementary Figure S3C). This evidence concerns the gene BTG2 and neoplasm.